SAPCD2, as an oncogene, can promote cell proliferation and tumor development, potentially affecting pathways such as PI3K/Akt, MAPK, and Hippo, although its direct effect on immune checkpoints is not yet clear (Zhang et al., 2022). Here, AKT1 is linked to neoplasm.